NeoProfen (ibuprofen lysine) Solution

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   January 2016 ADVERSE REACTIONS Post marketing Experience *added term Pulmonary hypertension ...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts